Renuka Perla, MD
Internal Medicine · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 3
Offices
3 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Perla’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A99467 · Current
Licensed to practise in California · since 2007 · expires 2027-01-31 · Ntr University of Health Sciences, Vijayawada, Andhra Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$2,306
Medicare paid this office $2,306 for 25 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Screening mammography | 11 | $1,432 | $130 |
Who their Medicare patients are
25 Original Medicare patients in 2024. Average age 73 · Health risk score 1.30. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 72%.
The office billed $18,370, Medicare allowed $2,596 and paid $2,306; for 33 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 25 | 33 | 73 | 1.30 | $18,370 | $2,306 |
| 2023 | 22 | 26 | 71 | 1.81 | $12,922 | $1,212 |
| 2022 | 13 | 18 | 69 | 1.35 | $7,594 | $1,078 |
| 2021 | 15 | 26 | 70 | 0.68 | $8,324 | $705 |
| 2020 | 20 | 26 | 66 | 1.24 | $9,022 | $1,405 |
| 2019 | 66 | 98 | 69 | 1.22 | $42,757 | $4,150 |
| 2018 | 36 | 54 | 68 | 1.30 | $18,278 | $1,926 |
| 2017 | 33 | 48 | 67 | 1.01 | $15,489 | $1,278 |
| 2016 | 61 | 100 | 66 | 1.54 | $28,897 | $3,332 |
| 2015 | 58 | 92 | 68 | 1.19 | $20,851 | $2,767 |
| 2014 | 93 | 171 | 66 | 1.35 | $35,622 | $5,820 |
| 2013 | 39 | 55 | 63 | 1.44 | $10,219 | $2,349 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 3 services
| Screening mammography | 11 | $1,475 | $134 |
| Short return visit (20+ min) | 15 | $935 | $58 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $279 | $17 |
2018: 1 service
| Screening mammography | 11 | $1,434 | $130 |
2016: 4 services
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 12 | $1,580 | $132 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $192 | $12 |
| X-ray of chest, 2 views, front and side | 11 | $86 | $7 |
| Computer analysis of screening mammogram to assist detection of cancer | 12 | $83 | $7 |
2015: 1 service
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 25 | $445 | $18 |
2014: 4 services
| Short return visit (20+ min) | 33 | $1,362 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,358 | $59 |
| Administration of influenza virus vaccine | 12 | $373 | $31 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $356 | $14 |
Medicaid work
$333,707 in 2024
Medicaid paid $333,707 for 10,493 billed services this clinician did in 2024, up to 163 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 647 | $276,113 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 142 | $52,348 |
| Short return visit (20+ min) | 2,060 | $4,910 |
| Short return visit | 222 | $146 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 295 | $116 |
| New patient visit (30+ min) | 16 | $74 |
| Pain severity quantified; pain present (COA) (ONC) | 226 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 266 | $0 |
| Medication list documented in medical record (COA) | 1,252 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 959 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 27 | $0 |
| MOST RECENT LDL-C <100 MG/DL | 73 | $0 |
| 2024 | 10,493 | 20 | 163 | $333,707 |
| 2023 | 7,472 | 23 | 152 | $585,196 |
| 2022 | 6,696 | 19 | 160 | $487,307 |
| 2021 | 5,297 | 18 | 166 | $576,836 |
| 2020 | 5,095 | 8 | 170 | $672,374 |
| 2019 | 5,188 | 9 | 193 | $659,862 |
| 2018 | 4,747 | 7 | 204 | $826,810 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,371 | $568,027 |
| Short return visit (20+ min) | 2,658 | $6,566 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 17 | $6,231 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 212 | $2,020 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 59 | $1,327 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 176 | $265 |
| Short return visit | 186 | $205 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 40 | $187 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 625 | $182 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 38 | $88 |
| New patient visit (30+ min) | 20 | $72 |
| Albumin; urine (eg, microalbumin), quantitative | 22 | $26 |
2022
| Clinic visit/encounter, all-inclusive | 1,189 | $473,649 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 368 | $4,465 |
| Short return visit (20+ min) | 1,724 | $2,703 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 94 | $2,310 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose | 34 | $1,360 |
| Short return visit | 684 | $784 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 15 | $600 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose | 15 | $600 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 263 | $399 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 712 | $280 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 13 | $112 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 66 | $45 |
2021
| Clinic visit/encounter, all-inclusive | 1,423 | $567,944 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | 74 | $2,960 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 42 | $1,680 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 35 | $1,400 |
| Short return visit (20+ min) | 1,608 | $1,262 |
| Short return visit | 879 | $1,153 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 103 | $260 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 257 | $106 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 32 | $42 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 32 | $29 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 184 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 171 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,702 | $668,434 |
| Short return visit (20+ min) | 1,764 | $1,651 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 374 | $1,641 |
| Short return visit | 768 | $575 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 17 | $40 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 122 | $34 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 323 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 25 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,695 | $653,185 |
| Short return visit (20+ min) | 2,353 | $4,072 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 67 | $958 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 209 | $881 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 179 | $326 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 428 | $236 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 133 | $101 |
| Short return visit | 67 | $78 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 57 | $24 |
2018
| Clinic visit/encounter, all-inclusive | 2,160 | $821,021 |
| Short return visit (20+ min) | 1,855 | $4,560 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 170 | $416 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 228 | $320 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 25 | $256 |
| Short return visit | 75 | $137 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 234 | $101 |
Drugs they prescribed that Part D paid
$146,867
Pharmacies billed $146,867 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (104 of 2,870) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
2,641 generic and 216 brand-name prescriptions · $146,867 in drug cost · 18 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 18 | $20,968 | $1,165 |
| Eliquis | 13 | $13,812 | $1,062 |
| Wixela Inhub | 12 | $2,058 | $172 |
| Atorvastatin | 289 | $1,662 | $6 |
| Albuterol Sulfate Hfa | 55 | $1,519 | $28 |
See all 51 drugs
| Xarelto | 18 | $20,968 | $1,165 |
| Eliquis | 13 | $13,812 | $1,062 |
| Wixela Inhub | 12 | $2,058 | $172 |
| Atorvastatin | 289 | $1,662 | $6 |
| Albuterol Sulfate Hfa | 55 | $1,519 | $28 |
| Gabapentin | 105 | $1,509 | $14 |
| Levothyroxine | 138 | $1,223 | $9 |
| Amlodipine Besylate | 243 | $871 | $4 |
| Losartan | 126 | $865 | $7 |
| Hydrocodone-Acetaminophen | 58 | $819 | $14 |
| Famotidine | 71 | $790 | $11 |
| Metoprolol | 73 | $736 | $10 |
| Metformin | 130 | $650 | $5 |
| Tolterodine Tartrate Er | 11 | $575 | $52 |
| Tamsulosin | 59 | $564 | $10 |
| Atenolol | 69 | $519 | $8 |
| Nifedipine Er | 15 | $369 | $25 |
| Fosinopril | 34 | $367 | $11 |
| Omeprazole | 60 | $357 | $6 |
| Pantoprazole | 30 | $350 | $12 |
| Baclofen | 41 | $340 | $8 |
| Lisinopril | 50 | $330 | $7 |
| Simvastatin | 63 | $321 | $5 |
| Acetaminophen-Codeine | 32 | $313 | $10 |
| Fluticasone Propionate | 40 | $271 | $7 |
| Hydrochlorothiazide | 108 | $234 | $2 |
| Sertraline | 30 | $207 | $7 |
| Metoprolol | 40 | $204 | $5 |
| Fenofibrate | 12 | $201 | $17 |
| Divalproex | 11 | $197 | $18 |
| Glipizide | 30 | $188 | $6 |
| Hydrocortisone | 21 | $170 | $8 |
| Ibuprofen | 35 | $159 | $5 |
| Carvedilol | 27 | $151 | $6 |
| Diclofenac | 11 | $149 | $14 |
| Triamcinolone Acetonide | 26 | $141 | $5 |
| Metformin Hcl Er | 12 | $138 | $11 |
| Trazodone | 27 | $131 | $5 |
| Furosemide | 21 | $128 | $6 |
| Benazepril | 12 | $122 | $10 |
| Montelukast | 12 | $113 | $9 |
| Buspirone | 13 | $108 | $8 |
| Glimepiride | 18 | $101 | $6 |
| Clonidine | 11 | $91 | $8 |
| Hydroxyzine | 20 | $87 | $4 |
| Alendronate | 15 | $78 | $5 |
| Pravastatin | 11 | $71 | $6 |
| Cyclobenzaprine | 12 | $66 | $5 |
| Meclizine | 11 | $46 | $4 |
| Loperamide | 15 | $25 | $2 |
| Tramadol | 13 | $21 | $2 |
Year by year
| 2024 | 2,870 | 297 | 4% (104) | 8% | $146,867 |
| 2023 | 2,956 | 256 | 4% (115) | 11% | $268,483 |
| 2022 | 3,218 | 279 | 3% (94) | 14% | $292,465 |
| 2021 | 3,229 | 252 | 3% (100) | 13% | $243,017 |
| 2020 | 3,298 | 234 | 3% (112) | 16% | $243,760 |
| 2019 | 2,911 | 237 | 4% (101) | 15% | $216,197 |
| 2018 | 2,632 | 223 | 3% (82) | 15% | $158,271 |
| 2017 | 2,632 | 201 | 4% (103) | 16% | $148,219 |
| 2016 | 2,802 | 225 | 6% (177) | 13% | $158,094 |
| 2015 | 2,365 | 184 | 6% (150) | 15% | $145,362 |
| 2014 | 2,522 | 176 | 5% (125) | 17% | $140,716 |
| 2013 | 1,694 | 179 | 7% (122) | 18% | $89,564 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 58 drugs
| Xarelto | 24 | $27,539 | $1,147 |
| Jardiance | 16 | $24,180 | $1,511 |
| Tradjenta | 19 | $22,265 | $1,172 |
| Trulicity | 17 | $18,668 | $1,098 |
| Ozempic | 12 | $15,727 | $1,311 |
| Advair Diskus | 28 | $13,458 | $481 |
| Spiriva Handihaler | 11 | $8,152 | $741 |
| Symbicort | 17 | $7,158 | $421 |
| Atorvastatin | 286 | $6,985 | $24 |
| Atrovent Hfa | 12 | $5,797 | $483 |
| Gabapentin | 88 | $3,556 | $40 |
| Amlodipine Besylate | 274 | $3,346 | $12 |
| Losartan | 138 | $2,839 | $21 |
| Tamsulosin | 46 | $2,349 | $51 |
| Metformin | 148 | $2,312 | $16 |
| Levothyroxine | 115 | $2,248 | $20 |
| Tolterodine Tartrate Er | 15 | $2,127 | $142 |
| Albuterol Sulfate Hfa | 42 | $1,784 | $42 |
| Atenolol | 76 | $1,581 | $21 |
| Metoprolol | 59 | $1,284 | $22 |
| Hydrocodone-Acetaminophen | 62 | $1,261 | $20 |
| Ventolin Hfa | 17 | $1,157 | $68 |
| Omeprazole | 58 | $1,068 | $18 |
| Simvastatin | 61 | $927 | $15 |
| Fosinopril | 46 | $889 | $19 |
| Pantoprazole | 31 | $815 | $26 |
| Lisinopril | 50 | $812 | $16 |
| Metoprolol | 58 | $794 | $14 |
| Divalproex | 12 | $780 | $65 |
| Famotidine | 54 | $755 | $14 |
| Glipizide | 54 | $735 | $14 |
| Baclofen | 39 | $725 | $19 |
| Fenofibrate | 16 | $719 | $45 |
| Sertraline | 20 | $643 | $32 |
| Trazodone | 22 | $633 | $29 |
| Venlafaxine Hcl Er | 13 | $567 | $44 |
| Nifedipine Er | 15 | $546 | $36 |
| Furosemide | 40 | $536 | $13 |
| Fluticasone Propionate | 34 | $525 | $15 |
| Carvedilol | 22 | $489 | $22 |
| Pravastatin | 23 | $489 | $21 |
| Isosorbide Mononitrate Er | 16 | $463 | $29 |
| Acetaminophen-Codeine | 34 | $418 | $12 |
| Clopidogrel | 13 | $369 | $28 |
| Diclofenac | 16 | $369 | $23 |
| Hydrochlorothiazide | 94 | $353 | $4 |
| Buspirone | 13 | $339 | $26 |
| Metformin Hcl Er | 17 | $274 | $16 |
| Ibuprofen | 31 | $269 | $9 |
| Benazepril | 17 | $266 | $16 |
| Glimepiride | 15 | $178 | $12 |
| Hydrocortisone | 16 | $149 | $9 |
| Triamcinolone Acetonide | 20 | $131 | $7 |
| Alendronate | 11 | $124 | $11 |
| Loperamide | 13 | $123 | $9 |
| Meclizine | 17 | $114 | $7 |
| Tramadol | 13 | $105 | $8 |
| Cyclobenzaprine | 12 | $60 | $5 |
2022: 62 drugs
| Jardiance | 25 | $32,907 | $1,316 |
| Januvia | 28 | $31,713 | $1,133 |
| Tradjenta | 29 | $30,572 | $1,054 |
| Trulicity | 18 | $14,910 | $828 |
| Novolin 70-30 | 17 | $14,683 | $864 |
| Xarelto | 13 | $13,452 | $1,035 |
| Ozempic | 14 | $10,670 | $762 |
| Lantus Solostar | 21 | $9,219 | $439 |
| Atrovent Hfa | 16 | $7,368 | $460 |
| Advair Diskus | 18 | $6,917 | $384 |
| Symbicort | 14 | $6,235 | $445 |
| Myrbetriq | 11 | $5,570 | $506 |
| Atorvastatin | 310 | $5,096 | $16 |
| Basaglar Kwikpen U-100 | 17 | $4,435 | $261 |
| Flovent Hfa | 20 | $4,033 | $202 |
| Novolog Flexpen | 13 | $3,485 | $268 |
| Levothyroxine | 128 | $2,613 | $20 |
| Albuterol Sulfate Hfa | 55 | $2,368 | $43 |
| Gabapentin | 82 | $2,316 | $28 |
| Losartan | 166 | $1,911 | $12 |
| Metformin | 199 | $1,902 | $10 |
| Amlodipine Besylate | 211 | $1,752 | $8 |
| Ultra-Fine Short Pen Needle | 16 | $1,415 | $88 |
| Glipizide | 107 | $1,188 | $11 |
| Tamsulosin | 46 | $1,013 | $22 |
| Hydrocodone-Acetaminophen | 51 | $1,009 | $20 |
| Metoprolol | 60 | $982 | $16 |
| Omeprazole | 62 | $945 | $15 |
| Fosinopril | 43 | $890 | $21 |
| Ventolin Hfa | 15 | $883 | $59 |
| Divalproex | 11 | $762 | $69 |
| Famotidine | 43 | $758 | $18 |
| Fenofibrate | 13 | $748 | $58 |
| Atenolol | 69 | $736 | $11 |
| Ultra-Fine Mini Pen Needle | 12 | $701 | $58 |
| Baclofen | 21 | $679 | $32 |
| Metoprolol | 69 | $653 | $9 |
| Lisinopril | 60 | $636 | $11 |
| Nifedipine Er | 12 | $578 | $48 |
| Hydrochlorothiazide | 130 | $578 | $4 |
| Potassium Chloride | 11 | $566 | $51 |
| Pantoprazole | 34 | $566 | $17 |
| Simvastatin | 64 | $558 | $9 |
| Insulin | 14 | $554 | $40 |
| Sertraline | 17 | $484 | $28 |
| Fluticasone Propionate | 33 | $454 | $14 |
| Venlafaxine Hcl Er | 15 | $409 | $27 |
| Pravastatin | 25 | $381 | $15 |
| Acetaminophen-Codeine | 22 | $379 | $17 |
| Clopidogrel | 19 | $362 | $19 |
| Furosemide | 44 | $351 | $8 |
| Benazepril | 21 | $340 | $16 |
| Trazodone | 25 | $339 | $14 |
| Ibuprofen | 32 | $270 | $8 |
| Isosorbide Mononitrate Er | 12 | $258 | $22 |
| Valsartan | 11 | $255 | $23 |
| Hydrocortisone | 14 | $254 | $18 |
| Glimepiride | 22 | $216 | $10 |
| Cyclobenzaprine | 16 | $213 | $13 |
| Meclizine | 19 | $191 | $10 |
| Triamcinolone Acetonide | 28 | $176 | $6 |
| Metformin Hcl Er | 19 | $121 | $6 |
2021: 58 drugs
| Januvia | 40 | $43,614 | $1,090 |
| Trulicity | 23 | $22,513 | $979 |
| Novolin 70-30 | 22 | $19,099 | $868 |
| Jardiance | 13 | $16,756 | $1,289 |
| Atrovent Hfa | 21 | $10,261 | $489 |
| Lantus Solostar | 21 | $7,629 | $363 |
| Advair Diskus | 14 | $4,317 | $308 |
| Atorvastatin | 278 | $4,130 | $15 |
| Levothyroxine | 134 | $3,085 | $23 |
| Albuterol Sulfate Hfa | 46 | $2,076 | $45 |
| Metformin | 219 | $1,689 | $8 |
| Gabapentin | 92 | $1,601 | $17 |
| Amlodipine Besylate | 228 | $1,564 | $7 |
| Losartan | 135 | $1,496 | $11 |
| Ultra-Fine Mini Pen Needle | 19 | $1,318 | $69 |
| Metoprolol | 65 | $1,222 | $19 |
| Ventolin Hfa | 18 | $1,063 | $59 |
| Diclofenac | 15 | $1,051 | $70 |
| Glipizide | 118 | $966 | $8 |
| Hydrocodone-Acetaminophen | 47 | $953 | $20 |
| Atenolol | 74 | $882 | $12 |
| Fosinopril | 51 | $871 | $17 |
| Famotidine | 39 | $826 | $21 |
| Nifedipine Er | 16 | $817 | $51 |
| Proair Hfa | 12 | $782 | $65 |
| Divalproex | 11 | $735 | $67 |
| Hydrochlorothiazide | 138 | $722 | $5 |
| Ultra-Fine Short Pen Needle | 14 | $685 | $49 |
| Simvastatin | 71 | $614 | $9 |
| Omeprazole | 62 | $612 | $10 |
| Fenofibrate | 18 | $598 | $33 |
| Tamsulosin | 62 | $586 | $9 |
| Metoprolol | 60 | $566 | $9 |
| Insulin | 11 | $539 | $49 |
| Clopidogrel | 29 | $521 | $18 |
| Trazodone | 54 | $517 | $10 |
| Pantoprazole | 26 | $516 | $20 |
| Lisinopril | 63 | $508 | $8 |
| Fluticasone Propionate | 41 | $475 | $12 |
| Baclofen | 32 | $446 | $14 |
| Glimepiride | 31 | $419 | $14 |
| Sertraline | 23 | $392 | $17 |
| Furosemide | 48 | $382 | $8 |
| Benazepril | 20 | $347 | $17 |
| Pravastatin | 23 | $338 | $15 |
| Oxycodone-Acetaminophen | 11 | $298 | $27 |
| Acetaminophen-Codeine | 27 | $260 | $10 |
| Dicyclomine | 11 | $222 | $20 |
| Metformin Hcl Er | 20 | $171 | $9 |
| Donepezil | 14 | $167 | $12 |
| Ibuprofen | 32 | $165 | $5 |
| Buspirone | 12 | $147 | $12 |
| Carvedilol | 12 | $144 | $12 |
| Hydrocortisone | 12 | $133 | $11 |
| Cyclobenzaprine | 24 | $124 | $5 |
| Triamcinolone Acetonide | 11 | $120 | $11 |
| Alendronate | 11 | $79 | $7 |
| Tramadol | 14 | $42 | $3 |
2020: 64 drugs
| Januvia | 35 | $34,331 | $981 |
| Jardiance | 20 | $26,440 | $1,322 |
| Novolin 70-30 | 25 | $25,262 | $1,010 |
| Humulin 70/30 Kwikpen | 13 | $17,969 | $1,382 |
| Trulicity | 14 | $15,331 | $1,095 |
| Tradjenta | 11 | $14,041 | $1,276 |
| Xarelto | 13 | $10,008 | $770 |
| Lantus Solostar | 19 | $8,735 | $460 |
| Atrovent Hfa | 20 | $8,361 | $418 |
| Levothyroxine | 156 | $4,249 | $27 |
| Advair Diskus | 12 | $3,775 | $315 |
| Atorvastatin | 272 | $3,602 | $13 |
| Symbicort | 12 | $3,512 | $293 |
| Basaglar Kwikpen U-100 | 11 | $3,032 | $276 |
| Flovent Hfa | 12 | $2,357 | $196 |
| Ventolin Hfa | 39 | $2,281 | $58 |
| Metformin | 225 | $1,765 | $8 |
| Losartan | 149 | $1,588 | $11 |
| Gabapentin | 94 | $1,479 | $16 |
| Amlodipine Besylate | 217 | $1,294 | $6 |
| Hydrocodone-Acetaminophen | 59 | $1,171 | $20 |
| Metoprolol | 54 | $1,116 | $21 |
| Glipizide | 138 | $950 | $7 |
| Atenolol | 84 | $933 | $11 |
| Hydrochlorothiazide | 157 | $917 | $6 |
| Ultra-Fine Mini Pen Needle | 18 | $848 | $47 |
| Albuterol Sulfate Hfa | 15 | $840 | $56 |
| Proair Hfa | 15 | $828 | $55 |
| Fosinopril | 56 | $742 | $13 |
| Ultra-Fine Short Pen Needle | 16 | $728 | $45 |
| Baclofen | 37 | $667 | $18 |
| Fenofibrate | 20 | $651 | $33 |
| Omeprazole | 84 | $634 | $8 |
| Fluticasone Propionate | 47 | $611 | $13 |
| Famotidine | 28 | $610 | $22 |
| Pravastatin | 34 | $556 | $16 |
| Oxycodone-Acetaminophen | 12 | $519 | $43 |
| Lisinopril | 64 | $501 | $8 |
| Simvastatin | 78 | $488 | $6 |
| Clopidogrel | 22 | $482 | $22 |
| Insulin | 11 | $448 | $41 |
| Benazepril | 29 | $436 | $15 |
| Trazodone | 58 | $412 | $7 |
| Metoprolol | 45 | $382 | $8 |
| Nifedipine Er | 12 | $379 | $32 |
| Divalproex | 12 | $375 | $31 |
| Furosemide | 55 | $342 | $6 |
| Sertraline | 23 | $321 | $14 |
| Tamsulosin | 41 | $270 | $7 |
| Hydrocortisone | 15 | $232 | $15 |
| Acetaminophen-Codeine | 33 | $220 | $7 |
| Donepezil | 12 | $208 | $17 |
| Ibuprofen | 35 | $205 | $6 |
| Carvedilol | 16 | $201 | $13 |
| Diclofenac | 11 | $198 | $18 |
| Clotrimazole | 12 | $196 | $16 |
| Metformin Hcl Er | 15 | $181 | $12 |
| Triamcinolone Acetonide | 31 | $177 | $6 |
| Pantoprazole | 15 | $170 | $11 |
| Clonidine | 11 | $164 | $15 |
| Cyclobenzaprine | 20 | $137 | $7 |
| Glimepiride | 12 | $136 | $11 |
| Nabumetone | 11 | $129 | $12 |
| Hydroxyzine | 13 | $86 | $7 |
2019: 58 drugs
| Januvia | 26 | $26,990 | $1,038 |
| Novolin 70-30 | 26 | $21,423 | $824 |
| Humulin 70/30 Kwikpen | 12 | $15,773 | $1,314 |
| Lantus Solostar | 21 | $9,073 | $432 |
| Symbicort | 21 | $8,337 | $397 |
| Novolog | 13 | $7,388 | $568 |
| Atrovent Hfa | 14 | $5,218 | $373 |
| Novolog Flexpen | 15 | $4,784 | $319 |
| Basaglar Kwikpen U-100 | 17 | $4,288 | $252 |
| Advair Diskus | 14 | $4,215 | $301 |
| Atorvastatin | 201 | $3,348 | $17 |
| Levothyroxine | 129 | $3,271 | $25 |
| Flovent Hfa | 11 | $2,446 | $222 |
| Ventolin Hfa | 27 | $2,142 | $79 |
| Gabapentin | 108 | $1,998 | $18 |
| Metformin | 187 | $1,517 | $8 |
| Proair Hfa | 33 | $1,444 | $44 |
| Metoprolol | 34 | $1,364 | $40 |
| Losartan | 126 | $1,237 | $10 |
| Ultra-Fine Short Pen Needle | 17 | $1,136 | $67 |
| Amlodipine Besylate | 157 | $1,124 | $7 |
| Hydrocodone-Acetaminophen | 61 | $1,021 | $17 |
| Atenolol | 78 | $928 | $12 |
| Tamsulosin | 48 | $811 | $17 |
| Hydrochlorothiazide | 131 | $800 | $6 |
| Fluticasone Propionate | 53 | $747 | $14 |
| Baclofen | 39 | $737 | $19 |
| Omeprazole | 77 | $696 | $9 |
| Fosinopril | 47 | $665 | $14 |
| Glipizide | 83 | $609 | $7 |
| Pravastatin | 26 | $606 | $23 |
| Famotidine | 26 | $532 | $20 |
| Trazodone | 46 | $461 | $10 |
| Fenofibrate | 12 | $447 | $37 |
| Simvastatin | 75 | $441 | $6 |
| Benazepril | 35 | $423 | $12 |
| Lisinopril | 52 | $412 | $8 |
| Insulin | 11 | $393 | $36 |
| Fenofibrate | 11 | $389 | $35 |
| Ibuprofen | 48 | $363 | $8 |
| Hydrocortisone | 18 | $321 | $18 |
| Furosemide | 30 | $318 | $11 |
| Oxycodone-Acetaminophen | 11 | $311 | $28 |
| Metoprolol | 31 | $299 | $10 |
| Divalproex | 12 | $280 | $23 |
| Ranitidine | 16 | $279 | $17 |
| Clopidogrel | 11 | $251 | $23 |
| Sertraline | 16 | $248 | $16 |
| Metformin Hcl Er | 15 | $239 | $16 |
| Donepezil | 13 | $191 | $15 |
| Acetaminophen-Codeine | 26 | $191 | $7 |
| Glimepiride | 12 | $182 | $15 |
| Pantoprazole | 19 | $172 | $9 |
| Nabumetone | 11 | $172 | $16 |
| Triamcinolone Acetonide | 26 | $151 | $6 |
| Meclizine | 13 | $108 | $8 |
| Cyclobenzaprine | 19 | $102 | $5 |
| Naproxen | 11 | $88 | $8 |
2018: 54 drugs
| Januvia | 16 | $17,171 | $1,073 |
| Novolin 70-30 | 16 | $14,566 | $910 |
| Novolog | 17 | $9,763 | $574 |
| Humalog Kwikpen U-100 | 12 | $9,497 | $791 |
| Lantus | 12 | $8,176 | $681 |
| Novolog Flexpen | 16 | $7,613 | $476 |
| Lantus Solostar | 21 | $6,525 | $311 |
| Flovent Hfa | 19 | $5,414 | $285 |
| Symbicort | 11 | $3,893 | $354 |
| Atorvastatin | 173 | $3,201 | $19 |
| Levothyroxine | 115 | $2,848 | $25 |
| Ventolin Hfa | 36 | $2,544 | $71 |
| Gabapentin | 90 | $2,468 | $27 |
| Levemir Flextouch | 11 | $1,928 | $175 |
| Proair Hfa | 24 | $1,399 | $58 |
| Metformin | 166 | $1,273 | $8 |
| Tamsulosin | 42 | $1,114 | $27 |
| Metoprolol | 26 | $1,059 | $41 |
| Losartan | 126 | $1,059 | $8 |
| Omeprazole | 95 | $953 | $10 |
| Atenolol | 80 | $876 | $11 |
| Amlodipine Besylate | 132 | $872 | $7 |
| Insulin | 14 | $793 | $57 |
| Pravastatin | 27 | $791 | $29 |
| Hydrocodone-Acetaminophen | 38 | $763 | $20 |
| Hydrochlorothiazide | 135 | $700 | $5 |
| Oxycodone-Acetaminophen | 17 | $632 | $37 |
| Fosinopril | 46 | $599 | $13 |
| Fenofibrate | 12 | $577 | $48 |
| Glipizide | 76 | $576 | $8 |
| Benazepril | 41 | $440 | $11 |
| Trazodone | 56 | $397 | $7 |
| Fluticasone Propionate | 27 | $376 | $14 |
| Lisinopril | 42 | $367 | $9 |
| Simvastatin | 68 | $344 | $5 |
| Baclofen | 25 | $324 | $13 |
| Divalproex | 12 | $310 | $26 |
| Clopidogrel | 16 | $302 | $19 |
| Furosemide | 38 | $297 | $8 |
| Ranitidine | 20 | $288 | $14 |
| Nabumetone | 14 | $286 | $20 |
| Carvedilol | 28 | $276 | $10 |
| Metoprolol | 38 | $274 | $7 |
| Ibuprofen | 34 | $252 | $7 |
| Famotidine | 11 | $249 | $23 |
| Fluoxetine | 11 | $231 | $21 |
| Sertraline | 14 | $218 | $16 |
| Metformin Hcl Er | 18 | $215 | $12 |
| Acetaminophen-Codeine | 25 | $205 | $8 |
| Sumatriptan | 11 | $188 | $17 |
| Triamcinolone Acetonide | 26 | $185 | $7 |
| Pantoprazole | 20 | $171 | $9 |
| Alendronate | 14 | $116 | $8 |
| Cephalexin | 11 | $63 | $6 |
2017: 51 drugs
| Januvia | 15 | $16,213 | $1,081 |
| Humalog Kwikpen U-100 | 13 | $10,993 | $846 |
| Lantus | 16 | $10,398 | $650 |
| Novolog | 17 | $9,427 | $555 |
| Novolin 70-30 | 17 | $8,634 | $508 |
| Lantus Solostar | 15 | $7,627 | $508 |
| Novolog Flexpen | 12 | $5,211 | $434 |
| Flovent Hfa | 12 | $3,011 | $251 |
| Atorvastatin | 152 | $2,806 | $18 |
| Levothyroxine | 107 | $2,635 | $25 |
| Metformin | 187 | $1,720 | $9 |
| Ventolin Hfa | 28 | $1,414 | $51 |
| Proair Hfa | 24 | $1,322 | $55 |
| Fenofibrate | 21 | $1,289 | $61 |
| Gabapentin | 70 | $1,240 | $18 |
| Amlodipine Besylate | 136 | $1,130 | $8 |
| Losartan | 135 | $1,121 | $8 |
| Hydrocodone-Acetaminophen | 63 | $995 | $16 |
| Tamsulosin | 30 | $940 | $31 |
| Atenolol | 90 | $895 | $10 |
| Insulin | 20 | $884 | $44 |
| Omeprazole | 101 | $851 | $8 |
| Pravastatin | 25 | $775 | $31 |
| Hydrochlorothiazide | 135 | $731 | $5 |
| Baclofen | 44 | $617 | $14 |
| Metoprolol | 36 | $594 | $17 |
| Oxycodone-Acetaminophen | 16 | $563 | $35 |
| Metoprolol | 13 | $550 | $42 |
| Simvastatin | 82 | $508 | $6 |
| Glipizide | 57 | $497 | $9 |
| Fosinopril | 46 | $485 | $11 |
| Fluticasone Propionate | 33 | $468 | $14 |
| Clopidogrel | 20 | $391 | $20 |
| Benazepril | 31 | $388 | $13 |
| Lisinopril | 36 | $373 | $10 |
| Nabumetone | 17 | $336 | $20 |
| Carvedilol | 29 | $302 | $10 |
| Famotidine | 20 | $287 | $14 |
| Fluoxetine | 24 | $269 | $11 |
| Furosemide | 34 | $268 | $8 |
| Clotrimazole | 20 | $267 | $13 |
| Hydrocortisone | 15 | $258 | $17 |
| Ibuprofen | 37 | $236 | $6 |
| Acetaminophen-Codeine | 23 | $231 | $10 |
| Trazodone | 37 | $187 | $5 |
| Triamcinolone Acetonide | 27 | $182 | $7 |
| Sertraline | 12 | $180 | $15 |
| Clonidine | 11 | $175 | $16 |
| Alendronate | 13 | $101 | $8 |
| Hydroxyzine | 13 | $82 | $6 |
| Naproxen | 12 | $76 | $6 |
2016: 51 drugs
| Lantus | 14 | $19,226 | $1,373 |
| Humalog Kwikpen U-100 | 17 | $16,784 | $987 |
| Lantus Solostar | 17 | $9,733 | $573 |
| Vesicare | 17 | $7,892 | $464 |
| Novolin N | 19 | $5,234 | $275 |
| Levothyroxine | 141 | $3,695 | $26 |
| Atorvastatin | 137 | $2,868 | $21 |
| Hydrocodone-Acetaminophen | 98 | $2,346 | $24 |
| Fenofibrate | 44 | $2,154 | $49 |
| Oxycodone | 12 | $2,127 | $177 |
| Metformin | 173 | $1,627 | $9 |
| Oxycodone-Acetaminophen | 35 | $1,491 | $43 |
| Gabapentin | 86 | $1,234 | $14 |
| Losartan | 124 | $1,152 | $9 |
| Pravastatin | 27 | $1,016 | $38 |
| Omeprazole | 92 | $960 | $10 |
| Proair Hfa | 13 | $932 | $72 |
| Atenolol | 88 | $904 | $10 |
| Baclofen | 48 | $881 | $18 |
| Amlodipine Besylate | 132 | $873 | $7 |
| Ventolin Hfa | 16 | $750 | $47 |
| Metoprolol | 16 | $726 | $45 |
| Insulin | 18 | $723 | $40 |
| Simvastatin | 107 | $692 | $6 |
| Fosinopril | 57 | $664 | $12 |
| Lisinopril | 42 | $626 | $15 |
| Hydrochlorothiazide | 133 | $618 | $5 |
| Famotidine | 13 | $608 | $47 |
| Fluticasone Propionate | 49 | $568 | $12 |
| Glipizide | 60 | $547 | $9 |
| Tamsulosin | 26 | $527 | $20 |
| Ibuprofen | 59 | $481 | $8 |
| Oxybutynin Chloride | 15 | $409 | $27 |
| Benazepril | 37 | $368 | $10 |
| Insulin | 12 | $332 | $28 |
| Acetaminophen-Codeine | 26 | $293 | $11 |
| Trazodone | 48 | $287 | $6 |
| Triamcinolone Acetonide | 39 | $284 | $7 |
| Metoprolol | 38 | $279 | $7 |
| Sertraline | 23 | $275 | $12 |
| Polyethylene Glycol 3350 | 12 | $270 | $22 |
| Hydrocortisone | 13 | $242 | $19 |
| Furosemide | 36 | $242 | $7 |
| Nabumetone | 11 | $223 | $20 |
| Diclofenac | 12 | $220 | $18 |
| Fluoxetine | 12 | $203 | $17 |
| Clotrimazole | 14 | $188 | $13 |
| Clopidogrel | 13 | $170 | $13 |
| Alendronate | 17 | $117 | $7 |
| Sumatriptan | 14 | $115 | $8 |
| Cyclobenzaprine | 13 | $70 | $5 |
2015: 42 drugs
| Lantus | 20 | $18,528 | $926 |
| Vesicare | 33 | $10,912 | $331 |
| Novolog Mix 70-30 | 11 | $6,816 | $620 |
| Atrovent Hfa | 13 | $5,312 | $409 |
| Levothyroxine | 135 | $3,968 | $29 |
| Proair Hfa | 43 | $2,402 | $56 |
| Gabapentin | 68 | $2,248 | $33 |
| Pravastatin | 41 | $2,187 | $53 |
| Hydrocodone-Acetaminophen | 93 | $2,150 | $23 |
| Oxycodone-Acetaminophen | 35 | $1,657 | $47 |
| Atorvastatin | 67 | $1,492 | $22 |
| Metformin | 120 | $1,374 | $11 |
| Omeprazole | 89 | $1,048 | $12 |
| Losartan | 90 | $1,024 | $11 |
| Fenofibrate | 32 | $1,002 | $31 |
| Simvastatin | 118 | $763 | $6 |
| Atenolol | 90 | $742 | $8 |
| Amlodipine Besylate | 111 | $713 | $6 |
| Metoprolol | 16 | $647 | $40 |
| Baclofen | 32 | $584 | $18 |
| Tamsulosin | 24 | $568 | $24 |
| Fosinopril | 35 | $547 | $16 |
| Hydrochlorothiazide | 104 | $538 | $5 |
| Diclofenac | 27 | $519 | $19 |
| Oxybutynin Chloride | 16 | $502 | $31 |
| Insulin | 12 | $471 | $39 |
| Fluticasone Propionate | 42 | $464 | $11 |
| Ibuprofen | 52 | $450 | $9 |
| Lisinopril | 31 | $425 | $14 |
| Glipizide | 34 | $394 | $12 |
| Benazepril | 33 | $333 | $10 |
| Sertraline | 22 | $239 | $11 |
| Acetaminophen-Codeine | 20 | $215 | $11 |
| Hydrocortisone | 13 | $208 | $16 |
| Metoprolol | 33 | $201 | $6 |
| Triamcinolone Acetonide | 30 | $184 | $6 |
| Clotrimazole | 15 | $180 | $12 |
| Famotidine | 17 | $164 | $10 |
| Trazodone | 27 | $141 | $5 |
| Furosemide | 17 | $124 | $7 |
| Alendronate | 15 | $119 | $8 |
| Paroxetine | 11 | $61 | $6 |
2014: 50 drugs
| Lantus | 18 | $18,620 | $1,034 |
| Humalog | 12 | $16,172 | $1,348 |
| Atrovent Hfa | 26 | $8,683 | $334 |
| Vesicare | 29 | $8,673 | $299 |
| Novolog Flexpen | 11 | $3,895 | $354 |
| Proair Hfa | 58 | $3,175 | $55 |
| Advair Diskus | 11 | $3,152 | $287 |
| Levothyroxine | 131 | $3,043 | $23 |
| Lidoderm | 11 | $2,947 | $268 |
| Gabapentin | 88 | $2,682 | $30 |
| Hydrocodone-Acetaminophen | 79 | $1,770 | $22 |
| Metformin | 147 | $1,767 | $12 |
| Losartan | 97 | $1,735 | $18 |
| Atorvastatin | 55 | $1,591 | $29 |
| Pravastatin | 39 | $1,476 | $38 |
| Omeprazole | 95 | $1,315 | $14 |
| Fluticasone Propionate | 57 | $1,272 | $22 |
| Oxycodone-Acetaminophen | 29 | $1,174 | $40 |
| Simvastatin | 124 | $1,154 | $9 |
| Fenofibrate | 26 | $1,132 | $44 |
| Insulin | 16 | $998 | $62 |
| Atenolol | 114 | $980 | $9 |
| Metoprolol | 14 | $839 | $60 |
| Potassium Chloride | 18 | $673 | $37 |
| Diclofenac | 35 | $640 | $18 |
| Amlodipine Besylate | 99 | $624 | $6 |
| Fosinopril | 36 | $614 | $17 |
| Glipizide | 49 | $575 | $12 |
| Hydrochlorothiazide | 104 | $544 | $5 |
| Benazepril | 34 | $514 | $15 |
| Ventolin Hfa | 11 | $511 | $46 |
| Oxybutynin Chloride | 15 | $475 | $32 |
| Bupropion Hcl Sr | 12 | $405 | $34 |
| Ibuprofen | 49 | $391 | $8 |
| Metoprolol | 49 | $389 | $8 |
| Sertraline | 19 | $353 | $19 |
| Nabumetone | 12 | $348 | $29 |
| Tamsulosin | 13 | $344 | $26 |
| Cyclobenzaprine | 16 | $329 | $21 |
| Trazodone | 47 | $241 | $5 |
| Alendronate | 22 | $226 | $10 |
| Amitriptyline | 15 | $221 | $15 |
| Methocarbamol | 12 | $208 | $17 |
| Sumatriptan | 11 | $194 | $18 |
| Lisinopril | 12 | $187 | $16 |
| Clotrimazole | 13 | $172 | $13 |
| Triamcinolone Acetonide | 29 | $168 | $6 |
| Baclofen | 12 | $168 | $14 |
| Verapamil Er | 13 | $119 | $9 |
| Furosemide | 23 | $110 | $5 |
2013: 34 drugs
| Vesicare | 13 | $5,069 | $390 |
| Atrovent Hfa | 13 | $3,859 | $297 |
| Spiriva | 11 | $3,049 | $277 |
| Losartan | 62 | $1,938 | $31 |
| Hydrocodone-Acetaminophen | 91 | $1,814 | $20 |
| Metformin | 112 | $1,737 | $16 |
| Gabapentin | 48 | $1,656 | $34 |
| Atorvastatin | 34 | $1,633 | $48 |
| Simvastatin | 103 | $1,378 | $13 |
| Levothyroxine | 83 | $1,332 | $16 |
| Omeprazole | 58 | $1,229 | $21 |
| Pioglitazone | 13 | $1,201 | $92 |
| Fluticasone Propionate | 34 | $1,011 | $30 |
| Proair Hfa | 16 | $987 | $62 |
| Atenolol | 98 | $886 | $9 |
| Nifedical Xl | 14 | $779 | $56 |
| Fosinopril | 31 | $771 | $25 |
| Amlodipine Besylate | 64 | $673 | $11 |
| Diclofenac | 16 | $648 | $41 |
| Benazepril | 30 | $486 | $16 |
| Glyburide | 12 | $468 | $39 |
| Glipizide | 27 | $425 | $16 |
| Hydrochlorothiazide | 62 | $383 | $6 |
| Tamsulosin | 11 | $323 | $29 |
| Sertraline | 15 | $269 | $18 |
| Alendronate | 16 | $264 | $16 |
| Ibuprofen | 35 | $249 | $7 |
| Trazodone | 34 | $231 | $7 |
| Metoprolol | 20 | $219 | $11 |
| Acetaminophen-Codeine | 17 | $186 | $11 |
| Cyclobenzaprine | 13 | $165 | $13 |
| Furosemide | 20 | $131 | $7 |
| Lisinopril | 15 | $123 | $8 |
| Oxycodone-Acetaminophen | 11 | $93 | $8 |
Professional record
- NPI
- 1710183074
- Licence
- CA A99467California A99467: Current · expires 2027-01-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2007-06-25
- NPI last updated
- 2013-08-08
This is when the NPI record was last certified, not a medical board exam.